A number of countries have published their own clinical guideline recommendations relating to screening and management of diabetic retinopathy (DR) in people with diabetes (Table 1). Specific recommendations vary between countries, often reflecting differences between healthcare system structure (e.g. private vs public) and levels of health care resources available (e.g. health care personnel, access to diagnostic equipment and treatments).
The two largest global ophthalmology and diabetes societies (the International Council of Ophthalmology [ICO] and the International Diabetes Federation [IDF]) have also published international guidelines for diabetic eye care, which include specific recommendations for screening, diagnosis and treatment of DR (Table 2).
Table 1: Countries with national guidelines containing recommendations relating to screening of diabetic retinopathy